Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for ErbB 321 found (468 total)

alternate case: erbB

Neuregulin 3 (2,559 words) [view diff] case mismatch in snippet view article find links to article

co-receptor as it has not been observed to bind any ligand. NRGs bind to the ERBB receptors to promote phosphorylation of specific tyrosine residues on the
Canertinib (241 words) [view diff] exact match in snippet view article find links to article
inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 nM) and ErbB-4 (IC50 7 nM). By 2015, Pfizer had discontinued development of the drug.
Tau-protein kinase (404 words) [view diff] case mismatch in snippet view article find links to article
(protein-serine/threonine kinases). This enzyme participates in 14 metabolic pathways: erbb signaling pathway, cell cycle, wnt signaling pathway, hedgehog signaling
V-erbA-related gene (668 words) [view diff] exact match in snippet view article find links to article
after its similarity to v-erbA (P03373), a helper of an oncoprotein called v-erbB in avian erythroblastosis virus. Comparatively little is known about ear-2
Neuregulin 4 (413 words) [view diff] exact match in snippet view article find links to article
(April 1999). "Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase". Oncogene. 18 (17): 2681–9. doi:10.1038/sj.onc
Betacellulin (1,786 words) [view diff] case mismatch in snippet view article find links to article
soluble factors can bind and activate the homodimer or heterodimer of the ERBB receptors. The membrane-anchored form of the betacellulin can activate the
Germinoma (984 words) [view diff] exact match in snippet view article find links to article
carboxypeptidase II erbB-3 receptor Early prostate cancer antigen-2 SPINK1 GOLM1 PCA3 TMPRSS2 hPG80 Germ cell tumor NANOG Bladder cancer erbB-3 receptor NMP22
ERRFI1 (932 words) [view diff] case mismatch in snippet view article find links to article
ERBB receptor feedback inhibitor 1 is a protein that in humans is encoded by the ERRFI1 gene. MIG6 is a Cytoplasmic protein whose expression is upregulated
Targeted covalent inhibitors (2,061 words) [view diff] exact match in snippet view article find links to article
wild-type EGFR that are expected to lead to a wider therapeutic index. The pan-ErbB inhibitor Neratinib was approved in the US in 2017 and in the EU in 2018
PA2G4 (1,255 words) [view diff] exact match in snippet view article find links to article
Hamburger AW (February 2000). "Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin". British Journal of Cancer
Epidermal growth factor (1,708 words) [view diff] exact match in snippet view article find links to article
EJ (July 2002). "Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display". Biochemistry. 41 (27): 8732–41.
Oncogenic retroviridae protein (133 words) [view diff] exact match in snippet view article find links to article
v-fms, ras, v-myc, v-src, v-akt, v-cbl, v-crk, v-maf, v-abl, v-erbA, v-erbB, v-fos, v-mos, v-myb, v-raf, v-rel, and v-sis. The "v" prefix indicates viral
Phosphatidylinositol-4,5-bisphosphate 3-kinase (298 words) [view diff] case mismatch in snippet view article find links to article
enzyme participates in 29 metabolic pathways: inositol phosphate metabolism, erbb signaling pathway, phosphatidylinositol signaling system, mtor signaling
Dale Webster (477 words) [view diff] case mismatch in snippet view article find links to article
Guinness Book of World Records. Scholastic Inc. ISBN 978-0-439-86562-3. erBB "Daily Dale in Guinness Book of World Records". Surfy Surfy. 2008-04-23.
Zinc finger transcription factor (561 words) [view diff] exact match in snippet view article find links to article
potential including correction of abnormal gene expression profiles (e.g., erbB-2 overexpression in human adenocarcinomas) and anti-retrovirals (e.g. HIV-1)
Matuzumab (842 words) [view diff] exact match in snippet view article find links to article
Retrieved January 5, 2010. Leahy DJ (April 2008). "A molecular view of anti-ErbB monoclonal antibody therapy". Cancer Cell. 13 (4): 291–3. doi:10.1016/j.ccr
Stuart A. Aaronson (1,387 words) [view diff] exact match in snippet view article find links to article
oncogene and its role in growth factor signaling. His discovery of erbB2 as a v-erbB-related gene amplified in a human breast carcinoma and the demonstration
FGF20 (221 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Imgatuzumab (124 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Emibetuzumab (117 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Keratinocyte growth factor (182 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
GRB7 (1,579 words) [view diff] case mismatch in snippet view article find links to article
(Mar 1997). "Molecular cloning of human GRB-7 co-amplified with CAB1 and c-ERBB-2 in primary gastric cancer". Biochemical and Biophysical Research Communications
FGF22 (203 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Duligotuzumab (87 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Futuximab (127 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Epigen (201 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Icrucumab (139 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Dusigitumab (89 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Flanvotumab (59 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Futuximab (127 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF15/19 (257 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Seribantumab (124 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
List of MeSH codes (G14) (3,088 words) [view diff] case mismatch in snippet view article
791.295 – genes, erbb MeSH G14.340.024.340.383.500.791.295.300 – genes, erbb-1 MeSH G14.340.024.340.383.500.791.295.305 – genes, erbb-2 MeSH G14.340.024
Alacizumab pegol (35 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ficlatuzumab (173 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Robatumumab (178 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Glia maturation factor (115 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Fasinumab (142 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Foretinib (183 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Rilotumumab (127 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ganitumab (130 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Norwogonin (174 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Tovetumab (150 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ertumaxomab (118 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Persephin (394 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Heparin-binding EGF-like growth factor (2,598 words) [view diff] exact match in snippet view article find links to article
1–3. doi:10.1093/jb/mvr120. PMID 21976708. Iwamoto R, Mekada E (2006). "ErbB and HB-EGF signaling in heart development and function". Cell Struct. Funct
GFRA4 (80 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Figitumumab (298 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
YAP1 (3,445 words) [view diff] exact match in snippet view article find links to article
protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus"
Nesvacumab (170 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
CSPG5 (456 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
GFRA3 (644 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Insulin-like growth factor-binding protein (468 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Onartuzumab (424 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Tavilermide (381 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Linsitinib (286 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Becaplermin (412 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
LM22A-4 (300 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Fulranumab (205 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
K252a (275 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Diosmetin (145 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Grandinin (359 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
MARCKS (1,376 words) [view diff] exact match in snippet view article find links to article
(May 2001). "Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation". Biochemical and Biophysical Research Communications. 283 (2):
FGF3 (790 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
7,8,3'-Trihydroxyflavone (249 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Colony-stimulating factor (374 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Lenograstim (149 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Deoxygedunin (653 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Dalotuzumab (624 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
60S ribosomal protein L19 (927 words) [view diff] exact match in snippet view article find links to article
expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2". Cancer Res. 53 (6): 1403–8. PMID 8095182. Maruyama K, Sugano S (1994)
Evinacumab (677 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
T-cell growth factor (228 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Trofinetide (892 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Dalotuzumab (624 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF17 (694 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Deoxygedunin (653 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Eutropoflavin (334 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ephrin A3 (684 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
R13 (drug) (263 words) [view diff] exact match in snippet view article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
PDGFB (434 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
SNTB2 (1,011 words) [view diff] exact match in snippet view article find links to article
S2CID 20910888. Garcia RA, Vasudevan K, Buonanno A (2000). "The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses". Proc. Natl
IGFBP2 (887 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ephrin A4 (667 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF11 (171 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ephrin A2 (714 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Cenegermin (389 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Growth factor (1,131 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF6 (606 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
IGFBP5 (904 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
TOB1 (1,287 words) [view diff] exact match in snippet view article find links to article
(May 2001). "Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation". Biochemical and Biophysical Research Communications. 283 (2):
Trafermin (249 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Dihexa (492 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FOXA1 (967 words) [view diff] exact match in snippet view article find links to article
breast cancer with a role for androgen receptor and implies interactions with ErbB family". BMC Medical Genomics. 2: 59. doi:10.1186/1755-8794-2-59. PMC 2753593
ETV4 (1,071 words) [view diff] exact match in snippet view article find links to article
Van Seuningen I (Feb 2005). "The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications
STAT5A (1,831 words) [view diff] exact match in snippet view article find links to article
Schulze WX, Deng L, Mann M (2005). "Phosphotyrosine interactome of the ErbB-receptor kinase family". Mol. Syst. Biol. 1 (1): E1 – E13. doi:10.1038/msb4100012
ANA-12 (588 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Hepatoma-derived growth factor (900 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Zalutumumab (571 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
PTPN18 (796 words) [view diff] case mismatch in snippet view article find links to article
dephosphorylation dephosphorylation ERBB2 signaling pathway negative regulation of ERBB signaling pathway cellular response to cytokine stimulus blastocyst formation
Ancestim (257 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
GFRA2 (gene) (812 words) [view diff] exact match in snippet view article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF7 (1,231 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Artemin (1,184 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
MMP16 (982 words) [view diff] exact match in snippet view article find links to article
transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2". Cancer Cell. 6 (3): 251–61. doi:10.1016/j.ccr.2004.07.012. PMID 15380516
R7 (drug) (692 words) [view diff] exact match in snippet view article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
ANGPT4 (679 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Molgramostim (120 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Mecasermin (314 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Murodermin (80 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
IGFBP4 (1,224 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF16 (275 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ephrin B1 (1,097 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Julian Downward (830 words) [view diff] exact match in snippet view article find links to article
cellular growth regulatory protein and the avian retroviral oncogene, v-erbB. This work led to the identification of the closely related cellular oncogene
Cyclotraxin B (335 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ephrin A1 (860 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
PDGFD (793 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Nimotuzumab (823 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ephrin B1 (1,097 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Tanezumab (645 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Motesanib (956 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Cerebrolysin (1,177 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Gossypetin (290 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Teprotumumab (1,041 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Des(1-3)IGF-1 (346 words) [view diff] exact match in snippet view article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
BNN-20 (572 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
ANGPT2 (1,113 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
IGFBP1 (1,045 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Sargramostim (876 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ephrin A5 (1,211 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ephrin B2 (1,320 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Thrombopoietin (1,066 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Genistein (4,467 words) [view diff] exact match in snippet view article find links to article
"Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation". Carcinogenesis
PTPN11 (4,304 words) [view diff] exact match in snippet view article find links to article
Schulze WX, Deng L, Mann M (2005). "Phosphotyrosine interactome of the ErbB-receptor kinase family". Mol. Syst. Biol. 1 (1): E1 – E13. doi:10.1038/msb4100012
Cyclin-dependent kinase 5 (5,162 words) [view diff] exact match in snippet view article find links to article
binding protein kinase activity protein serine/threonine kinase activity ErbB-3 class receptor binding transferase activity ephrin receptor binding tau-protein
GFRA1 (1,493 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Neurotrophin-4 (1,241 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
C-fos-induced growth factor (1,253 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF15 (748 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Lipegfilgrastim (435 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Renalase (1,789 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
IGF-1 LR3 (412 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
CTGF (1,537 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Gamma secretase (2,211 words) [view diff] exact match in snippet view article find links to article
Carpenter G (2001). "gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase". Science. 294 (5549): 2179–81. doi:10.1126/science
Gamma secretase (2,211 words) [view diff] exact match in snippet view article find links to article
Carpenter G (2001). "gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase". Science. 294 (5549): 2179–81. doi:10.1126/science
PDGFC (1,369 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
MST1 (901 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Barry Gusterson (2,412 words) [view diff] exact match in snippet view article find links to article
collaboration resulted in numerous publications, including the demonstration of c-erbB-2 (HER2) overexpression as a prognostic indicator in breast cancer and suggested
PDGFA (1,108 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Vascular endothelial growth factor B (1,558 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ephrin B3 (1,023 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
SH3BGRL (343 words) [view diff] exact match in snippet view article find links to article
Schulze WX, Deng L, Mann M (2006). "Phosphotyrosine interactome of the ErbB-receptor kinase family". Mol. Syst. Biol. 1 (1): 2005.0008. doi:10.1038/msb4100012
PTPN12 (1,621 words) [view diff] case mismatch in snippet view article find links to article
epidermal growth factor stimulus ERBB2 signaling pathway negative regulation of ERBB signaling pathway negative regulation of platelet-derived growth factor receptor-beta
Sprifermin (544 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Insulin-like growth factor (1,689 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Mecasermin rinfabate (1,227 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
BNN-27 (615 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Neurturin (1,477 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF4 (1,874 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Palifermin (1,288 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Pleiotrophin (1,649 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Oncomodulin (1,257 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
ADCYAP1R1 (1,555 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
HIOC (369 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ki-67 (protein) (1,365 words) [view diff] exact match in snippet view article
PMID 20152769. Bánkfalvi A (November 2000). "Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in
Transforming growth factor (596 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF9 (1,756 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
TGF alpha (2,112 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
List of intestinal stem cell marker genes (2,143 words) [view diff] exact match in snippet view article find links to article
Aronow, B. J.; Haigis, K. M.; Franklin, J. L.; Coffey, R. J. (2012). "The Pan-ErbB Negative Regulator Lrig1 is an Intestinal Stem Cell Marker that Functions
IFNA2 (2,608 words) [view diff] exact match in snippet view article find links to article
Divisekera U, Ngiow SF, Duret H, Yagita H, Teng MW, Smyth MJ (April 2011). "Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1
N-Acetylserotonin (1,154 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Pituitary adenylate cyclase-activating peptide (1,724 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Pegaptanib (1,230 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF5 (2,251 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
List of intestinal stem cell marker genes (2,143 words) [view diff] exact match in snippet view article find links to article
Aronow, B. J.; Haigis, K. M.; Franklin, J. L.; Coffey, R. J. (2012). "The Pan-ErbB Negative Regulator Lrig1 is an Intestinal Stem Cell Marker that Functions
Angiopoietin 1 (1,623 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
TP53RK (581 words) [view diff] exact match in snippet view article find links to article
transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2". Cancer Cell. 6 (3): 251–61. doi:10.1016/j.ccr.2004.07.012. PMID 15380516
Ephrin (2,476 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FMS-like tyrosine kinase 3 ligand (724 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Mucin 4 (2,092 words) [view diff] exact match in snippet view article find links to article
Molecular function extracellular matrix constituent, lubricant activity ErbB-2 class receptor binding Cellular component Golgi lumen extracellular region
LRIG1 (763 words) [view diff] exact match in snippet view article find links to article
(2004). "The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases". J. Biol. Chem. 279 (45): 47050–6. doi:10
Fibroblast growth factor 23 (1,840 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF12 (639 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
IGFBP7 (2,499 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
TMF1 (659 words) [view diff] exact match in snippet view article find links to article
(2002). "Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1". Oncogene. 21 (36): 5609–18. doi:10.1038/sj.onc
Keilor Downs College (287 words) [view diff] case mismatch in snippet view article find links to article
branched out to other universities, such as Emir's Royal Bosnian Barracks or ERBB for short. "Home". kdc.vic.edu.au. "Keilor Downs College - Issue 17: VCE
Ciliary neurotrophic factor (1,748 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Neurotrophin-3 (1,820 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF10 (1,790 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
GRB2 (9,365 words) [view diff] exact match in snippet view article find links to article
Graus-Porta D, Beerli RR, Rohrer J, Gay B, Hynes NE (September 1998). "ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization
Adrenomedullin (2,597 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Pegfilgrastim (998 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF14 (879 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Placental growth factor (1,923 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
MAPK1 (2,283 words) [view diff] case mismatch in snippet view article find links to article
DNA-binding transcription factor activity animal organ morphogenesis cell cycle ERBB signaling pathway apoptotic process B cell receptor signaling pathway regulation
Insulin-like growth factor 2 (1,931 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Fibroblast growth factor (3,126 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Midkine (2,372 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
GeneRIF (564 words) [view diff] exact match in snippet view article find links to article
absence of punctuation and of sentence-initial capital letters. p53 and c-erbB-2 may have independent role in carcinogenesis of gall bladder cancer Degradation
FGF19 (2,570 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
DNAJA3 (1,956 words) [view diff] exact match in snippet view article find links to article
organization, and hyperthickened skin. DNAJA3 has been shown to interact with: ErbB-2 receptor tyrosine kinase MK5 HSPA9 HSPA8, JAK2, and RASA1 ENSG00000103423
Major vault protein (1,419 words) [view diff] case mismatch in snippet view article find links to article
transport mRNA transport negative regulation of protein tyrosine kinase activity ERBB signaling pathway negative regulation of signaling negative regulation of
Hepatocyte growth factor (2,623 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Poziotinib (189 words) [view diff] exact match in snippet view article find links to article
Develop Core Technologies". BusinessKorea. Roskoski R (September 2014). "ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors".
Midkine (2,372 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
MAPK/ERK pathway (3,068 words) [view diff] exact match in snippet view article find links to article
Schulze WX, Deng L, Mann M (2005). "Phosphotyrosine interactome of the ErbB-receptor kinase family". Molecular Systems Biology. 1 (1): 2005.0008. doi:10
Crenolanib (2,068 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF18 (2,154 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
FGF13 (824 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
STAT3 (3,340 words) [view diff] exact match in snippet view article find links to article
PMID 15485908. Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE (June 1999). "ErbB receptor-induced activation of stat transcription factors is mediated by
Erythropoietin (3,431 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Thomas Graf (biologist) (771 words) [view diff] exact match in snippet view article
S2CID 4371767. Graf, Thomas; Beug, Hartmut (1983-08-01). "Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation"
ProtCID (721 words) [view diff] case mismatch in snippet view article find links to article
interfaces of homologous proteins identified by ProtCID -- similar homodimers of ERBB kinases (EGFR, ERBB2, ERBB4) associated with kinase activation. Each monomer
Friedrich Miescher Institute for Biomedical Research (1,547 words) [view diff] exact match in snippet view article find links to article
Gullick WJ, Waterfield MD, Groner B, Hynes NE (March 1988). "Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with
DLG2 (1,095 words) [view diff] exact match in snippet view article find links to article
PMID 10648730. Garcia RA, Vasudevan K, Buonanno A (2000). "The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses". Proc. Natl
Orlistat (3,469 words) [view diff] exact match in snippet view article find links to article
apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene". Annals of Oncology. 16 (8): 1253–1267. doi:10.1093/annonc/mdi239
Tropoflavin (2,230 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Fibroblast growth factor 2 (2,698 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Vascular endothelial growth factor C (3,104 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Mothers against decapentaplegic homolog 7 (2,851 words) [view diff] exact match in snippet view article find links to article
2003). "An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors". Mol. Cell. 12 (3): 541–52. doi:10.1016/S1097-2765(03)00350-2
Filgrastim (1,852 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Nepidermin (1,174 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
PTGES3 (966 words) [view diff] exact match in snippet view article find links to article
Yoo JY, Hamburger AW (1999). "Interaction of the p23/p198 protein with ErbB-3". Gene. 229 (1–2): 215–221. doi:10.1016/S0378-1119(98)00604-0. PMID 10095121
Potato carboxypeptidase inhibitor (605 words) [view diff] exact match in snippet view article find links to article
epidermal growth factor (EGF). PCI blocks the formation and activation of ErbB1/ErbB-2 (EGFR and HER2) heterodimers that have a prominent role in carcinoma development
Stem cell factor (2,954 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ranibizumab (2,785 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Integrin (3,928 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Amphiregulin (3,297 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
PLXNB1 (1,248 words) [view diff] exact match in snippet view article find links to article
"Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2". J. Cell Biol. 165 (6): 869–80. doi:10.1083/jcb.200312094. PMC 2172401
Nerve growth factor (3,110 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
STAT1 (3,768 words) [view diff] exact match in snippet view article find links to article
PMID 11909970. Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE (June 1999). "ErbB receptor-induced activation of stat transcription factors is mediated by
Glial cell line-derived neurotrophic factor (2,883 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Glucose-6-phosphate isomerase (3,057 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
DLG3 (1,389 words) [view diff] exact match in snippet view article find links to article
PMID 10595517. Garcia RA, Vasudevan K, Buonanno A (2000). "The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses". Proc. Natl
Brolucizumab (1,147 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Ponazuril (241 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Glucose-6-phosphate isomerase (3,057 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
EPHA10 (138 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Vascular endothelial growth factor A (3,053 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Robert Roskoski (507 words) [view diff] exact match in snippet view article find links to article
and regulation. Pharmacol. Res. 66, 105–143. Roskoski R Jr. (2014) The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol. Res. 79, 34–74
Neurotrophic factors (1,784 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Plakoglobin (4,516 words) [view diff] exact match in snippet view article find links to article
Ochiai A, Shibata T, Oyama T, Ushijima S, Akimoto S, et al. (March 1995). "c-erbB-2 gene product directly associates with beta-catenin and plakoglobin". Biochemical
GFRα (109 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Cerulenin (567 words) [view diff] exact match in snippet view article find links to article
(July 2004). "Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells". Proc. Natl. Acad. Sci. U.S.A
Growth factor receptor inhibitor (387 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
GATA3 (3,723 words) [view diff] exact match in snippet view article find links to article
breast cancer with a role for androgen receptor and implies interactions with ErbB family". BMC Medical Genomics. 2: 59. doi:10.1186/1755-8794-2-59. PMC 2753593
GDNF family of ligands (1,125 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Erbin (protein) (1,517 words) [view diff] exact match in snippet view article
Gene ontology Molecular function structural constituent of cytoskeleton ErbB-2 class receptor binding protein binding signaling receptor binding Cellular
DLG4 (2,725 words) [view diff] exact match in snippet view article find links to article
Garcia RA, Vasudevan K, Buonanno A (March 2000). "The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses". Proc. Natl
Akt/PKB signaling pathway (4,072 words) [view diff] exact match in snippet view article find links to article
Akt mediated DNA repair in radioresistance of solid tumors overexpressing erbB-PI3K-Akt pathway". Translational Cancer Research. 2 (3). doi:10.3978/j.issn
Vascular endothelial growth factor (4,578 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Dehydroepiandrosterone sulfate (2,570 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
LGMN (771 words) [view diff] case mismatch in snippet view article find links to article
process negative regulation of neuron apoptotic process negative regulation of ERBB signaling pathway renal system process antigen processing and presentation
Fibroblast growth factor 1 (2,311 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Insulin-like growth factor 1 (4,591 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Dexamethasone (6,527 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
DDX10 (695 words) [view diff] exact match in snippet view article find links to article
transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2". Cancer Cell. 6 (3): 251–61. doi:10.1016/j.ccr.2004.07.012. PMID 15380516
PSMC3 (2,428 words) [view diff] exact match in snippet view article find links to article
of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinases". Proc. Natl. Acad. Sci. U.S.A. 96 (11): 6434–8
Brain-derived neurotrophic factor (5,879 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Capicua (protein) (1,435 words) [view diff] exact match in snippet view article
Scotting PJ (Jun 2005). "CIC, a gene involved in cerebellar development and ErbB signaling, is significantly expressed in medulloblastomas". J Neurooncol
Neurotrophin (3,081 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
List of MeSH codes (D12.776.543) (11,308 words) [view diff] case mismatch in snippet view article
factor MeSH D12.776.543.750.060.374 – receptor, erbb-2 MeSH D12.776.543.750.060.437 – receptor, erbb-3 MeSH D12.776.543.750.060.468 – receptor, igf type
Receptor activity-modifying protein (533 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
IGFBP3 (4,717 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Faricimab (1,570 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Angiopoietin (2,363 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Dehydroepiandrosterone (4,056 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Hemopoietic growth factor (544 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Cell signaling (6,707 words) [view diff] exact match in snippet view article find links to article
Michael; Lerdrup, Mads; van Deurs, Bo (May 2008). "Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer". Histochemistry and Cell Biology
Wnt signaling pathway (7,432 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
CBLB (gene) (1,393 words) [view diff] exact match in snippet view article
Schulze WX, Deng L, Mann M (2005). "Phosphotyrosine interactome of the ErbB-receptor kinase family". Mol. Syst. Biol. 1: E1 – E13. doi:10.1038/msb4100012
Amitriptyline (8,744 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Prasterone sulfate (556 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Amitriptyline/perphenazine (554 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Saliva testing (8,483 words) [view diff] exact match in snippet view article find links to article
T, Dai X, Kingman A, Thigpen JT (June 2000). "The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study"
List of MeSH codes (D23) (8,039 words) [view diff] case mismatch in snippet view article
prostate-specific antigen MeSH D23.101.840.642 – receptor, erbb-2 MeSH D23.101.840.721 – receptor, erbb-3 MeSH D23.101.840.800 – synaptophysin MeSH D23.101.840
Bispecific monoclonal antibody (3,542 words) [view diff] exact match in snippet view article find links to article
December 11, 2023. Yarden Y, Sliwkowski MX (February 2001). "Untangling the ErbB signalling network". Nature Reviews. Molecular Cell Biology. 2 (2): 127–137
Cyclin D1 (5,694 words) [view diff] exact match in snippet view article find links to article
Hung MC, Rabbani SA, Datar R, Cote R, Pestell R, Albanese C (May 2007). "ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in
ALTO-100 (3,943 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Greg Lemke (1,393 words) [view diff] exact match in snippet view article find links to article
mammalian genomes. These novel RTKs included new members of the Eph, FGFR, and ErbB families, but also defined two entirely new RTK families. Much of the subsequent
TMEFF2 (1,189 words) [view diff] exact match in snippet view article find links to article
containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells". Biochemical and Biophysical Research Communications
Insulin (13,818 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Fibroblast growth factor 21 (3,038 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
PIK3R1 (3,136 words) [view diff] exact match in snippet view article find links to article
Gene ontology Molecular function ErbB-3 class receptor binding phosphatidylinositol 3-kinase regulator activity insulin-like growth factor receptor binding
Testosterone (15,759 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Index of oncology articles (5,119 words) [view diff] exact match in snippet view article find links to article
hole – buserelin – buspirone – busulfan – buthionine sulfoximine C cell – c-erbB-2 – c-kit – CA 19-9 assay – CA-125 – CA-125 test – cachexia – calcitonin
Prasterone enanthate (1,826 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Anti-VEGF (1,693 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Androgen receptor (9,471 words) [view diff] exact match in snippet view article find links to article
(August 2002). "Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1". Oncogene. 21 (36): 5609–18. doi:10.1038/sj.onc
Exosome (vesicle) (7,565 words) [view diff] case mismatch in snippet view article
cell survival and metastasis. In breast cancers, neratinib, a novel pan-ERBB inhibitor, is able to downmodulate the amount of HER2 released by exosomes
RBPJ (1,484 words) [view diff] case mismatch in snippet view article find links to article
transition positive regulation of BMP signaling pathway positive regulation of ERBB signaling pathway blood vessel endothelial cell fate specification negative
Fibroblast growth factor receptor-like 1 (842 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
NDRG1 (2,179 words) [view diff] exact match in snippet view article find links to article
Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways".
Adapter molecule crk (2,943 words) [view diff] exact match in snippet view article find links to article
9614078 Schulze WX, Deng L, Mann M (2005). "Phosphotyrosine interactome of the ErbB-receptor kinase family". Mol. Syst. Biol. 1 (1): E1 – E13. doi:10.1038/msb4100012
Breast development (6,495 words) [view diff] exact match in snippet view article find links to article
(1998). "Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis". Cell Growth Differ. 9 (9): 777–85
Laboratory Syrian hamster (3,877 words) [view diff] exact match in snippet view article find links to article
Werkmeister, R; Brandt, B; Joos, U (January 2000). "Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas". Oral Oncology. 36 (1): 100–5. doi:10
List of MeSH codes (D12.776) (7,397 words) [view diff] case mismatch in snippet view article
p56(lck) MeSH D12.776.624.664.700.642 – receptor, erbb-2 MeSH D12.776.624.664.700.790 – receptor, erbb-3 MeSH D12.776.624.664.700.800 – receptor, macrophage
Prasterone (7,649 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Testosterone (medication) (10,800 words) [view diff] exact match in snippet view article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
RAMP1 (1,146 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
RAMP3 (1,066 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
RAMP2 (1,169 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Enteropathy-associated T-cell lymphoma (5,544 words) [view diff] case mismatch in snippet view article find links to article
mutations in VAV1, rearrangements of the ITK gene with the SYK, FER, and ERBB genes, and/or rearrangements of the TP63 gene. However, ALCL also has distinctive
List of human clusters of differentiation (492 words) [view diff] exact match in snippet view article find links to article
adrenocortical carcinoma patients CD340 Receptor tyrosine-protein kinase erbB-2, HER2 (human epidermal growth factor receptor 2) or HER2/neu. Overexpression
C-Met inhibitor (3,542 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Microbubble (3,928 words) [view diff] exact match in snippet view article find links to article
Shan (May 2019). "Ultrasound microbubble-mediated CRISPR/Cas9 knockout of C-erbB-2 in HEC-1A cells". Journal of International Medical Research. 47 (5): 2199–2206
List of MeSH codes (D08) (15,232 words) [view diff] case mismatch in snippet view article
811.913.696.620.682.725.400.150 – receptor, erbb-2 MeSH D08.811.913.696.620.682.725.400.175 – receptor, erbb-3 MeSH D08.811.913.696.620.682.725.400.185
Gilbertian mimicry (745 words) [view diff] exact match in snippet view article find links to article
result is long-lasting hypersensitivity in bitten mammals, implying that ErbB is involved in signalling mammalian pain. The mechanism is, according to
Cancer systems biology (3,591 words) [view diff] exact match in snippet view article find links to article
unknown, complementary and potentially superior mechanism of inhibiting the ErbB receptor signaling network. ErbB3 was found to be the most sensitive node
Proteases in angiogenesis (5,457 words) [view diff] exact match in snippet view article find links to article
an initial step for the activation of specific receptors such as Notch, ErbB-4 and the angiopoietin receptor Tie-1. Notch-1 signaling is essential for
Fosgonimeton (102 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Estradiol valerate/prasterone enanthate (882 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Zinc finger chimera (4,966 words) [view diff] exact match in snippet view article find links to article
"Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from
Pediatric ependymoma (4,967 words) [view diff] case mismatch in snippet view article find links to article
Junttila, TT; Frank, AJ; Haapasalo, H; Connelly, M; Wetmore, C; et al. (2002). "ERBB receptor signaling promotes ependymoma cell proliferation and represents
Tumour heterogeneity (7,134 words) [view diff] exact match in snippet view article find links to article
Mihatsch, M. J.; Waldman, F. M. (1995). "Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer". Cytometry.
Risk factors of schizophrenia (14,934 words) [view diff] exact match in snippet view article find links to article
spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system". Proc Natl Acad Sci U S A. 106 (11):
Adult neurogenesis (12,331 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Equal Rights Beyond Borders (2,309 words) [view diff] case mismatch in snippet view article find links to article
Sight: The mistreatment of asylum seekers in Greece' published jointly with ERBB 2021-05-26". resourcecentre.savethechildren.net. 2021-05-26. Retrieved 5
Braegen-02 (278 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Testosterone propionate/testosterone cypionate/prasterone (253 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
ACD856 (940 words) [view diff] exact match in snippet view article find links to article
Nesvacumab (against angiopoietin 2) CNTF Agonists: Axokine CNTF Dapiclermin EGF (ErbB) FGF HGF (c-Met) Agonists: Fosgonimeton Hepatocyte growth factor Potentiators:
Indraneel Mittra (2,723 words) [view diff] exact match in snippet view article find links to article
(October 1995). "Prognosis of breast cancer: Evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes". Journal of